BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26377355)

  • 1. Prevalence and determinants of white coat effect in a large UK hypertension clinic population.
    Thomas O; Shipman KE; Day K; Thomas M; Martin U; Dasgupta I
    J Hum Hypertens; 2016 Jun; 30(6):386-91. PubMed ID: 26377355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interarm Difference in Systolic Blood Pressure in Different Ethnic Groups and Relationship to the "White Coat Effect": A Cross-Sectional Study.
    Schwartz CL; Clark C; Koshiaris C; Gill PS; Greenfield SM; Haque SM; Heer G; Johal A; Kaur R; Mant J; Martin U; Mohammed MA; Wood S; McManus RJ
    Am J Hypertens; 2017 Sep; 30(9):884-891. PubMed ID: 28475667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treated hypertension and the white coat phenomenon: Office readings are inadequate measures of efficacy.
    Agarwal R; Weir MR
    J Am Soc Hypertens; 2013; 7(3):236-43. PubMed ID: 23523137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White-Coat and Reverse White-Coat Effects Correlate with 24-h Pulse Pressure and Systolic Blood Pressure Variability in Children and Young Adults.
    Fujita H; Matsuoka S; Awazu M
    Pediatr Cardiol; 2016 Feb; 37(2):345-52. PubMed ID: 26481222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABPM Induced Alarm Reaction: A Possible Cause of Overestimation of Daytime Blood Pressure Values Reduced By Treatment with Beta-Blockers.
    Salvo F; Lonati C; Albano M; Fogliacco P; Errani AR; Vallo C; Berardi M; Meinero V; Muzzulini CL; Morganti A
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):255-8. PubMed ID: 27272934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does home blood pressure allow for a better assessment of the white-coat effect than ambulatory blood pressure?
    Saladini F; Benetti E; Malipiero G; Casiglia E; Palatini P
    J Hypertens; 2012 Nov; 30(11):2118-24. PubMed ID: 23027180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing white-coat effect.
    Manios ED; Koroboki EA; Tsivgoulis GK; Spengos KM; Spiliopoulou IK; Brodie FG; Vemmos KN; Zakopoulos NA
    Am J Hypertens; 2008 Feb; 21(2):153-8. PubMed ID: 18174883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study.
    Ghazi L; Cohen LP; Muntner P; Shimbo D; Drawz PE
    Hypertension; 2020 Oct; 76(4):1090-1096. PubMed ID: 32829666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White coat effect and masked uncontrolled hypertension in treated hypertensive-diabetic patients: Prevalence and target organ damage.
    Leiria LF; Severo MD; Ledur PS; Becker AD; Aguiar FM; Massierer D; Freitas VC; Schaan BD; Gus M
    J Diabetes; 2015 Sep; 7(5):699-707. PubMed ID: 25327439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The white-coat effect is an independent predictor of myocardial ischemia in resistant hypertension.
    Modolo R; Ruggeri Barbaro N; de Faria AP; Rodrigues Sabbatini A; Paganelli MO; Fontana V; Moreno H
    Blood Press; 2014 Oct; 23(5):276-80. PubMed ID: 24571101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinic and ambulatory blood pressure in a population-based sample of African Americans: the Jackson Heart Study.
    Thomas SJ; Booth JN; Bromfield SG; Seals SR; Spruill TM; Ogedegbe G; Kidambi S; Shimbo D; Calhoun D; Muntner P
    J Am Soc Hypertens; 2017 Apr; 11(4):204-212.e5. PubMed ID: 28285829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients.
    Pierdomenico SD; Pierdomenico AM; Coccina F; Porreca E
    Am J Hypertens; 2017 Nov; 30(11):1106-1111. PubMed ID: 29059303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory blood pressure monitoring in kidney transplant patients: RETENAL study.
    Fernandez Fresnedo G; Franco Esteve A; Gómez Huertas E; Cabello Chaves V; Díz Gómez JM; Osorio Moratalla JM; Gallego Samper R; Gallego Valcárcel E; Campistol Plana JM; Marín Iranzo R; Arias Rodríguez M;
    Transplant Proc; 2012 Nov; 44(9):2601-2. PubMed ID: 23146468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension.
    Muxfeldt ES; Fiszman R; de Souza F; Viegas B; Oliveira FC; Salles GF
    Hypertension; 2012 Feb; 59(2):384-9. PubMed ID: 22215711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the white-coat effect among hypertensive patients presumed to be at goal.
    Bookstaver DA; Hatzigeorgiou C
    Ann Pharmacother; 2011 Jul; 45(7-8):910-5. PubMed ID: 21750311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term antihypertensive treatment on white-coat hypertension.
    Mancia G; Facchetti R; Parati G; Zanchetti A
    Hypertension; 2014 Dec; 64(6):1388-98. PubMed ID: 25245386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypotension based on office and ambulatory monitoring blood pressure. Prevalence and clinical profile among a cohort of 70,997 treated hypertensives.
    Divisón-Garrote JA; Banegas JR; De la Cruz JJ; Escobar-Cervantes C; De la Sierra A; Gorostidi M; Vinyoles E; Abellán-Aleman J; Segura J; Ruilope LM
    J Am Soc Hypertens; 2016 Sep; 10(9):714-23. PubMed ID: 27451950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study for white coat effect in Japanese middle-aged to elderly people: The HOMED-BP study.
    Ogata S; Kamide K; Asayama K; Tabara Y; Kawaguchi T; Satoh M; Katsuya T; Sugimoto K; Hirose T; Inoue R; Hara A; Obara T; Kikuya M; Metoki H; Matsuda F; Staessen JA; Ohkubo T; Rakugi H; Imai Y
    Clin Exp Hypertens; 2018; 40(4):363-369. PubMed ID: 29058489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.